Acellular nerve allografts in peripheral nerve regeneration: A comparative study

Muscle and Nerve

Volumn 44, Issue 2, 2011, Pages 221-234

  Moore, Amy M ^a   MacEwan, Matthew ^a   Santosa, Katherine B ^a   Chenard, Kristofer E ^a   Ray, Wilson Z ^a   Hunter, Daniel A ^a   Mackinnon, Susan E ^a   Johnson, Philip J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acellular nerve allograft; Decellularization; Nerve tissue engineering; Peripheral nerve regeneration; Tissue processing

Indexed keywords

SILICONE;

ACELLULAR NERVE ALLOGRAFT; ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; DONOR; ELECTRON MICROSCOPY; FUNCTIONAL ASSESSMENT; GRAFT PRESERVATION; GRAFT RECIPIENT; ISOGRAFT; MALE; MORPHOMETRICS; NERVE INJURY; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SURGICAL TECHNIQUE;

ANIMALS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; NERVE REGENERATION; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; SCIATIC NERVE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79960516209     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22033     Document Type: Article

References (54)

1. Noble J, Munro CA, Prasad VS, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma 1998;45:116-122.
2. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA. The peripheral nerve allograft: an assessment of regeneration across nerve allografts in rats immunosuppressed with cyclosporin A. Plast Reconstruct Surg 1988;82:1052-1066.
3. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA. The peripheral nerve allograft: a dose-response curve in the rat immunosuppressed with cyclosporin A. Plast Reconstruct Surg 1988;82:447-457.
4. Strasberg SR, Hertl MC, Mackinnon SE, Lee CK, Watanabe O, Tarasidis G, et al. Peripheral nerve allograft preservation improves regeneration and decreases systemic cyclosporin A requirements. Exp Neurol 1996;139:306-316.
5. Midha R, Mackinnon SE, Evans PJ, Best TJ, Hare GM, Hunter DA, et al. Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. J Neurosurg 1993;78:90-100.
6. Brenner MJ, Moradzadeh A, Myckatyn TM, Tung TH, Mendez AB, Hunter DA, et al. Role of timing in assessment of nerve regeneration. Microsurgery 2008;28:265-272.
7. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstruct Surg 2001;107:1419-1429.
8. Mackinnon SE, Novak CB. Nerve transfers. New options for reconstruction following nerve injury. Hand Clinics 1999;15:643-666, ix.
9. Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Richards TM, et al. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc 1994;69:105-111.
10. Myckatyn TM, Mackinnon SE. A review of research endeavors to optimize peripheral nerve reconstruction. Neurol Res 2004;26:124-138.
11. Hiles RW. Freeze dried irradiated nerve homograft: a preliminary report. Hand 1972;4:79-84.
12. Johnson PC, Duhamel RC, Meezan E, Brendel K. Preparation of cellfree extracellular matrix from human peripheral nerve. Muscle Nerve 1982;5:335-344.
13. Sondell M, Lundborg G, Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res 1998;795:44-54.
14. Hudson TW, Liu SY, Schmidt CE. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 2004;10: 1346-1358.
15. Atchabahian A, Mackinnon SE, Hunter DA. Cold preservation of nerve grafts decreases expression of ICAM-1 and class II MHC antigens. J Reconstr Microsurg 1999;15:307-311.
16. Evans PJ, Mackinnon SE, Best TJ, Wade JA, Awerbuck DC, Makino AP, et al. Regeneration across preserved peripheral nerve grafts. Muscle Nerve 1995;18:1128-1138.
17. Evans PJ, Mackinnon SE, Levi AD, Wade JA, Hunter DA, Nakao Y, et al. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve 1998;21:1507-1522.
18. Evans PJ, MacKinnon SE, Midha R, Wade JA, Hunter DA, Nakao Y, et al. Regeneration across cold preserved peripheral nerve allografts. Microsurgery 1999;19:115-127.
19. Fox IK, Jaramillo A, Hunter DA, Rickman SR, Mohanakumar T, Mackinnon SE. Prolonged cold-preservation of nerve allografts. Muscle Nerve 2005;31:59-69.
20. Hudson TW, Zawko S, Deister C, Lundy S, Hu CY, Lee K, et al. Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng 2004;10:1641-1651.
21. Krekoski CA, Neubauer D, Zuo J, Muir D. Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan. J Neurosci 2001;21:6206-6213.
22. Neubauer D, Graham JB, Muir D. Chondroitinase treatment increases the effective length of acellular nerve grafts. Exp Neurol 2007;207:163-170.
23. Whitlock EL, Tuffaha SH, Luciano JP, Yan Y, Hunter DA, Magill CK, et al. Processed allografts and type I collagen conduits for repair of peripheral nerve gaps. Muscle Nerve 2009;39:787-799.
24. Fox IK, Schwetye KE, Keune JD, Brenner MJ, Yu JW, Hunter DA, et al. Schwann-cell injection of cold-preserved nerve allografts. Microsurgery 2005;25:502-507.
25. Hunter DA, Moradzadeh A, Whitlock EL, Brenner MJ, Myckatyn TM, Wei CH, et al. Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J Neurosci Methods 2007;166:116-124.
26. Urbanchek MS, Chung KC, Asato H, Washington LN, Kuzon WM Jr. Rat walking tracks do not reflect maximal muscle force capacity. J Reconstr Microsurg 1999;15:143-149.
27. Johnson PJ, Newton P, Hunter DA, Mackinnon SE. Nerve endoneurial microstructure facilitates uniform distribution of regenerative fibers: a post hoc comparison of midgraft nerve fiber densities. J Reconstr Microsurg 2011;27:83-90.
28. Hare GM, Evans PJ, Mackinnon SE, Nakao Y, Midha R, Wade JA, et al. Effect of cold preservation on lymphocyte migration into peripheral nerve allografts in sheep. Transplantation 1993;56:154-162.
29. Lundborg G, Dahlin LB, Danielsen N, Gelberman RH, Longo FM, Powell HC, et al. Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol 1982;76:361-375.
30. Williams LR, Longo FM, Powell HC, Lundborg G, Varon S. Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol 1983;218:460-470.
31. Hodde JP, Record RD, Liang HA, Badylak SF. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001;8:11-24.
32. Hodde JP, Ernst DM, Hiles MC. An investigation of the long-term bioactivity of endogenous growth factor in OASIS wound matrix. J Wound Care 2005;14:23-25.
33. Hodde J, Record R, Tullius R, Badylak S. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. Biomaterials 2002;23:1841-1848.
34. Hodde JP, Record RD, Tullius RS, Badylak SF. Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization. Tissue Eng 2002;8:225-234.
35. McDevitt CA, Wildey GM, Cutrone RM. Transforming growth factorbeta1 in a sterilized tissue derived from the pig small intestine submucosa. J Biomed Mater Res 2003;67:637-640.
36. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997;67:478-491.
37. Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, DeRuiter MC. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 2005;27:566-571.
38. Schenke-Layland K, Vasilevski O, Opitz F, Konig K, Riemann I, Halbhuber KJ, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003;143:201-208.
39. Danielsen N, Kerns JM, Holmquist B, Zhao Q, Lundborg G, Kanje M. Predegeneration enhances regeneration into acellular nerve grafts. Brain Res 1995;681:105-108.
40. Osawa T, Tohyama K, Ide C. Allogeneic nerve grafts in the rat, with special reference to the role of Schwann cell basal laminae in nerve regeneration. J Neurocytol 1990;19:833-849.
41. Braunewell KH, Pesheva P, McCarthy JB, Furcht LT, Schmitz B, Schachner M. Functional involvement of sciatic nerve-derived versican-and decorin-like molecules and other chondroitin sulphate proteoglycans in ECM-mediated cell adhesion and neurite outgrowth. Eur J Neurosci 1995;7:805-814.
42. Zuo J, Hernandez YJ, Muir D. Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injury. J Neurobiol 1998;34:41-54.
43. Morgenstern DA, Asher RA, Naidu M, Carlstedt T, Levine JM, Fawcett JW. Expression and glycanation of the NG2 proteoglycan in developing, adult, and damaged peripheral nerve. Mol Cell Neurosci 2003;24:787-802.
44. Hughes PM, Wells GM, Perry VH, Brown MC, Miller KM. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 2002;113:273-287.
45. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 1998;18: 5203-5211.
46. Kantor DB, Chivatakarn O, Peer KL, Oster SF, Inatani M, et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004;44:961-975.
47. Groves ML, McKeon R, Werner E, Nagarsheth M, Meador W, English AW. Axon regeneration in peripheral nerves is enhanced by proteoglycan degradation. Exp Neurol 2005;195:278-292.
48. Graham JB, Neubauer D, Xue QS, Muir D. Chondroitinase applied to peripheral nerve repair averts retrograde axonal regeneration. Exp Neurol 2007;203:185-195.
49. Zuo J, Neubauer D, Graham J, Krekoski CA, Ferguson TA,Muir D. Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp Neurol 2002;176:221-228.
50. Mackinnon SE, Hudson AR, Falk RE, Hunter DA. The nerve allograft response-an experimental model in the rat. Ann Plast Surg 1985;14:334-339.
51. Calvert GT, Doolabh VB, Grand AG, Hunter DA, Mackinnon SE. Rat-strain differences in recovery following peripheral-nerve allotransplantation. J Reconstr Microsurg 2001;17:185-191.
52. Strasberg JE, Strasberg S, Mackinnon SE, Watanabe O, Hunter DA, Tarasidis G. Strain differences in peripheral-nerve regeneration in rats. J Reconstr Microsurg 1999;15:287-293.
53. Neubauer D, Graham JB, Muir D. Chondroitinase treatment increases the effective length of acellular nerve grafts. Exp Neurol 2007;207:163-170.
54. Moore AM, Kasukurthi R, Magill CK, Farhadi HF, Borschel GH, Mackinnon SE. Limitations of conduits in peripheral nerve repairs. Hand (New York, NY) 2009;4:180-186.